Biomarkers for GVHD prognosis

Affiliations

¹ Department of Blood and Marrow Transplantation, Clinical Division, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA; Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA.
² Department of Blood and Marrow Transplantation, Clinical Division, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA; Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA. Electronic address: claudio.anasetti@moffitt.org.

Comment

Brian Betts et al. Lancet Haematol. 2015 Jan.

. 2015 Jan;2(1):e4-5.

doi: 10.1016/S2352-3026(14)00040-4. Epub 2014 Dec 23.

¹ Department of Blood and Marrow Transplantation, Clinical Division, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA; Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA.
² Department of Blood and Marrow Transplantation, Clinical Division, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA; Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA. Electronic address: claudio.anasetti@moffitt.org.

No abstract available

Comment on

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H, Magenau J, Weisdorf DJ, Ho VT, Bolaños-Meade J, Alousi AM, Ferrara JL; Blood and Marrow Transplant Clinical Trials Network. Levine JE, et al. Lancet Haematol. 2015 Jan;2(1):e21-9. doi: 10.1016/S2352-3026(14)00035-0. Epub 2014 Dec 23. Lancet Haematol. 2015. PMID: 26687425 Free PMC article. Clinical Trial.